GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gala Pharmaceutical Inc (OTCPK:GLPH) » Definitions » Gross Profit

Gala Pharmaceutical (Gala Pharmaceutical) Gross Profit : $0.00 Mil (TTM As of May. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Gala Pharmaceutical Gross Profit?

Gala Pharmaceutical's gross profit for the three months ended in May. 2019 was $0.00 Mil. Gala Pharmaceutical's gross profit for the trailing twelve months (TTM) ended in May. 2019 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Gala Pharmaceutical's gross profit for the three months ended in May. 2019 was $0.00 Mil. Gala Pharmaceutical's Revenue for the three months ended in May. 2019 was $0.00 Mil. Therefore, Gala Pharmaceutical's Gross Margin % for the quarter that ended in May. 2019 was N/A%.

Gala Pharmaceutical had a gross margin of N/A% for the quarter that ended in May. 2019 => No sustainable competitive advantage


Gala Pharmaceutical Gross Profit Historical Data

The historical data trend for Gala Pharmaceutical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gala Pharmaceutical Gross Profit Chart

Gala Pharmaceutical Annual Data
Trend Nov11 Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18
Gross Profit
Get a 7-Day Free Trial - - - - -

Gala Pharmaceutical Quarterly Data
Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gala Pharmaceutical's Gross Profit

For the Biotechnology subindustry, Gala Pharmaceutical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gala Pharmaceutical's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gala Pharmaceutical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Gala Pharmaceutical's Gross Profit falls into.



Gala Pharmaceutical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Gala Pharmaceutical's Gross Profit for the fiscal year that ended in Nov. 2018 is calculated as

Gross Profit (A: Nov. 2018 )=Revenue - Cost of Goods Sold
=0.005 - 0.004
=0.00

Gala Pharmaceutical's Gross Profit for the quarter that ended in May. 2019 is calculated as

Gross Profit (Q: May. 2019 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in May. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Gala Pharmaceutical's Gross Margin % for the quarter that ended in May. 2019 is calculated as

Gross Margin % (Q: May. 2019 )=Gross Profit (Q: May. 2019 ) / Revenue (Q: May. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Gala Pharmaceutical  (OTCPK:GLPH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Gala Pharmaceutical had a gross margin of N/A% for the quarter that ended in May. 2019 => No sustainable competitive advantage


Gala Pharmaceutical Gross Profit Related Terms

Thank you for viewing the detailed overview of Gala Pharmaceutical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Gala Pharmaceutical (Gala Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
18881 Von Karman Avenue, Suite 1440, Irvine, CA, USA, 92612
Gala Pharmaceutical Inc is a United States-based company engaged in the hemp and cannabidiol (CBD) industry. It is focused on the development, research, and commercialization of products derived from the hemp and cannabis plant. It is focused on CBD flavored thin-film strip which is an advanced method of providing CBD for the dietary supplement. The services offered by the company are the development of cannabinoid-based health and wellness products; development of medical grade compounds; licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry. The group earns revenue from the sale of products related to hemp and CBD, including modified electronic cigarettes and vape pens.